• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Nitrobenzoic acids and derivatives

Research Brief on 4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester (CAS: 86718-17-4)

4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester (CAS: 86718-17-4) is a nitrobenzoic acid derivative that has garnered significant attention in recent chemical and pharmaceutical research due to its potential applications in drug synthesis and biological activity modulation. This compound, characterized by its unique nitro and amino functional groups, serves as a key intermediate in the synthesis of various pharmacologically active molecules. Recent studies have explored its utility in the development of novel therapeutic agents, particularly in the fields of oncology and infectious diseases.

Recent research has focused on the synthesis and optimization of 4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester to enhance its yield and purity. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and confirm its structural integrity. These efforts are critical for ensuring the reproducibility and scalability of its production, which is essential for further pharmaceutical applications.

In the context of biological activity, preliminary studies have investigated the compound's potential as a precursor for the synthesis of antimicrobial and anticancer agents. For instance, derivatives of 4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester have shown promising activity against certain bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). Additionally, its nitro group has been implicated in the generation of reactive oxygen species (ROS), which could be leveraged for targeted cancer therapies.

Another area of interest is the compound's role in photodynamic therapy (PDT). Researchers have explored its ability to act as a photosensitizer, where upon light activation, it generates cytotoxic species that can selectively destroy cancer cells. This application is particularly relevant given the growing need for non-invasive treatment modalities with minimal side effects.

Despite these promising findings, challenges remain in the clinical translation of 4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester-based therapies. Issues such as bioavailability, toxicity, and stability under physiological conditions need to be addressed through further preclinical and clinical studies. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to overcome these hurdles and unlock the full potential of this compound.

In conclusion, 4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester (CAS: 86718-17-4) represents a versatile and promising intermediate in pharmaceutical research. Its applications span from antimicrobial and anticancer agent development to photodynamic therapy, highlighting its broad utility. Continued research and optimization will be crucial to translate these findings into clinically viable therapies, paving the way for innovative treatments in the chemical and biomedical fields.

• 34841-11-7(Methyl 2-methoxy-5-nitrobenzoate)
• 39106-79-1(Methyl 2-methoxy-4-nitrobenzoate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)